These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25304077)

  • 1. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
    Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scale-up of in vitro permeation assay data to human intestinal permeability using pore theory.
    Kataoka M; Iwai K; Masaoka Y; Sakane T; Sakuma S; Yamashita S
    Int J Pharm; 2011 Jul; 414(1-2):69-76. PubMed ID: 21596118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of oral drug absorption in humans by theoretical passive absorption model.
    Obata K; Sugano K; Saitoh R; Higashida A; Nabuchi Y; Machida M; Aso Y
    Int J Pharm; 2005 Apr; 293(1-2):183-92. PubMed ID: 15778056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans.
    Velický M; Tam KY; Dryfe RA
    Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
    Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
    Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
    Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
    Tam KY; Avdeef A; Tsinman O; Sun N
    J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs.
    Nagahara N; Tavelin S; Artursson P
    J Pharm Sci; 2004 Dec; 93(12):2972-84. PubMed ID: 15459946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model.
    Sugano K; Takata N; Machida M; Saitoh K; Terada K
    Int J Pharm; 2002 Jul; 241(2):241-51. PubMed ID: 12100852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
    Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
    J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
    Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
    J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.